1-7 of 7
Charlotte Graham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Practice Patterns of SGLT2 Inhibitor Use in Stem Cell Transplantation and CART Cell Therapy: A Study from the EBMT Transplant Complications Working Party

Christian R Schultze-Florey, Mouad Abouqateb, Christophe Peczynski, William Boreland, Pascale Ambron, Alberto Mussetti, Christian Koenecke, Charlotte Graham, Helene Schoemans, Olaf Penack, Ivan Sergeevich Moiseev, Zinaida Peric
Journal: Blood
Blood (2024) 144 (Supplement 1): 7605.
https://doi.org/10.1182/blood-2024-202598
Published: 2024
Journal Articles

Biological Correlatives of Efficacy and Toxicity of BCMA Targeting CAR T Cell Therapy in a Real-World Setting

Charlotte Graham, Aiyana Parker, Xiaomeng Sun, Nicholas J. Haradhvala, Maria Dolaher, Kevin Lindell, Deshea Harris, Won-Ho Lee, Kiana J Graham, Hannah K Nolan, Viktoria Blumenberg, David J Bozym, Alex Li, Hana Cho, Estelle Emmanuel-Alejandro, Arienne R Annati, Julianne Marie Gildea, Alexis Barselau, Diana Cirstea, Andrew R. Branagan, Andrew J. Yee, Noopur Raje, Gad Getz, Mark B Leick, Matthew Frigault, Kathleen Gallagher, Marcela V Maus
Journal: Blood
Blood (2024) 144 (Supplement 1): 7126.
https://doi.org/10.1182/blood-2024-194895
Published: 2024
Journal Articles

Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel

Mark B. Leick, Seunghun Han, Kathleen M.E. Gallagher, Harrison Silva, Grace Martin, Sabrina Camp, Hoyin Chu, Riaz Gillani, Michael C. Kann, Bryan D. Choi, Rebecca Larson, Merle Phillips, Tamina Kienka, Stefanie R. Bailey, Charlotte Graham, Christopher R. Reilly, Max Jan, Elba Gonzalez, Nora K. Horick, Justin Budka, Simone Filosto, Rhine R. Shen, Eliezer Van Allen, Saud H AlDubayan, Marcela V. Maus
Journal: Blood
Blood (2022) 140 (Supplement 1): 646–647.
https://doi.org/10.1182/blood-2022-166322
Published: 2022
Journal Articles

Allogeneic Anti-Bcma CAR-T Cells Show Tumour Specific Killing Against Primary Multiple Myeloma Cells from Different Genomic Sub-Groups

Ana M Metelo, PhD, Ieuan Walker, BSc, MSc, MBBS, Agnieszka Jozwik, PhD, Charlotte Graham, MRCP, BSc, MBBS, Charlotte Attwood, BMedSci, MBBS, MRCP, FRCPath, Katy Sanchez, BSc, MSc, Alan Dunlop, BSc, MSc, Kirsty Cuthill, FRCPath,MBBS,MRCP,PhD, Carmel Rice, FRACP, FRCPA, MBBS, Matthew Streetly, MD, Trevor Bentley, BSc, Bijan Boldajipour, PhD, Cesar Sommer, PhD, Barbra Sasu, PhD, Reuben Benjamin, FRCPath, MRCP, MBBS, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1834.
https://doi.org/10.1182/blood-2019-124312
Published: 2019
Journal Articles

Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies

Charlotte Graham, MRCP, BSc, MBBS, Agnieszka Jozwik, PhD, Ruby Quartey-Papafio, Nikolaos Ioannou, PhD MSc, BSc, Ana M Metelo, PhD, Carlo Scala, PhD, Glenda Dickson, PhD, Orla Stewart, Maria Almena-Carrasco, Elisa Peranzoni, Alan G. Ramsay, BSc,MSc,PhD, Sandra Dupouy, Pharm.D, PhD, Farzin Farzaneh, PhD, Piers E.M. Patten, BSc, MRCP, MRCPath, PhD, Andrea Pepper, PhD, Reuben Benjamin, FRCPath, MRCP, MBBS, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3228.
https://doi.org/10.1182/blood-2019-123018
Published: 2019
Journal Articles

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Reuben Benjamin, Charlotte Graham, MRCP, BSc, MBBS, Deborah Yallop, MBBS FRCP FRCPath PhD, Agnieszka Jozwik, Oana Ciocarlie, Nitin Jain, MD, Elias J. Jabbour, MD, Marcela V. Maus, MD PhD, Matthiew Frigault, MD MSc, Nicolas Boissel, MD PhD, Jerome Larghero, PharmD, PhD, Andre Baruchel, MD, Mohamad Mohty, MD PhD, Barbara De Moerloose, MD PhD, Adrian Bloor, MA MB BChir PhDFCRP FRCPath, Noelle V. Frey, MD, Amina Zinaï, MD, Svetlana Balandraud, MD, Anne Philippe, Pharm D, Sylvain Fouliard, Ludiane Gauthier, Jeanne Pauly, PharmD, Cyril Konto, MD, Candy Bermingham, PhD, Paul Veys, MD PhD, Waseem Qasim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 896.
https://doi.org/10.1182/blood-2018-99-111356
Published: 2018
Journal Articles

Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a First-in-Human Trial (CALM) in Adult Patients with CD19 + Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Charlotte Graham, MRCP, BSc, MBBS, Deborah Yallop, MBBS FRCP FRCPath PhD, Agnieszka Jozwik, Piers Patten, BSc, MRCP, MRCPath, PhD, Alan Dunlop, Rose Ellard, Orla Stewart, Victoria Potter, Victoria Metaxa, Shireen Kassam, Farzin Farzaneh, PhD, Stephen Devereux, FRCP, FRCPath, PhD, Antonio Pagliuca, MD, Amina Zinai, MD, Florence Binlich, MD, Sandra Dupouy, Pharm.D, PhD, Anne Philippe, Svetlana Balandraud, MD, Frédéric Dubois, Cyril Konto, MD, Premal Patel, MD PhD BSPharm, Ghulam Mufti, DM, FRCP, FRCPath, Reuben Benjamin
Journal: Blood
Blood (2017) 130 (Supplement 1): 887.
https://doi.org/10.1182/blood.V130.Suppl_1.887.887
Published: 2017